The Economic Revolution – Financial Weekly Newspaper Ahmedabad, Gujarat, India
IPOIPO Analysis By Dilip DavdaIPO Analysis EnglishIPO Right Issue in English

Crescentis Capital BSE RI Review

– By Dilip Davda

 

  • This is the 2nd RI from the company since June 2025.
  • Bumper performance in pre-RI period appears window dressing to fetch fancy valuations.
  • Based on its recent average financial data, the issue appears aggressively priced.
  • There is no harm in skipping this pricey and dicey bet.

 

ABOUT COMPANY:

Crescentis Capital Ltd., (CCL) erstwhile known as Som Datt Finance Corporate Ltd., is engaged in financial services as an RBI registered NBFC. Its major activities are investments in stock market, mutual funds etc. The offer document is silent on its employees’ strength data.

 

ISSUE DETAILS:

The company is coming out with its Rights Issue (RI) of 10208129 equity shares of Rs. 10 each at a fixed price of Rs. 78 per share to mobilize Rs. 79.62 cr. The RI opens for subscription on November 16, 2026, and will close on November 27, 2026. The company is offering RI in the ratio of 3 for 5 to its eligible stakeholders as of the record date of November 04, 2026. The company is asking for full money on application for number of shares applied. Post allotment, RI shares will be listed on BSE. The company is spending Rs. 0.70 cr. for this RI process, from the net proceeds, Rs. 63.30 cr. for augmenting its capital base, Rs. 15.00 cr. for repayment/prepayment of certain borrowings, Rs.0.62 cr. for general corporate purposes.

 

The RI is solely lead managed by the company itself, and RCMC Share Registry Pvt. Ltd. is the registrar to the issue.

 

Post-RI, company’s current paid-up equity capital of Rs. 17.01 cr. (17013549 equity shares) will stand enhanced to Rs. 27.22 cr. (27221678 shares). Based on the RI pricing, the company is looking for a market cap of Rs. 212.33 cr.

 

FINANCIAL PERFORMANCE:

On the financial performance front, for the last two fiscals, the company has posted total revenue / net profit, – (loss), of Rs. – (3.02) cr. / Rs – (5.42) cr. (FY25), Rs. 1.55 cr. / Rs.  – (2.53) cr. (FY26). For H1 of FY27 ended on September 30, 2026, it has earned a net profit of Rs. 6.72 cr. on a total income of Rs. 11.07 cr. It posted listless and erratic financial performance for the reported periods. H1-FY27 has spectacular performance for Q1 ended June 30, 2026, followed by average performance for Q2 ended September 30, 2026.

 

DIVIDEND POLICY:

The company has not paid any dividends for the last three years. It will adopt a prudent dividend policy, based on its financial performance and future prospects. The offer document is silent on its dividend policy.

 

SCRIP PERFORMANCE: BASED ON BSE WEBSITE DATA: SCRIP CODE: 511571 (FV Rs. 10).

The scrip last closed on cum-right basis at Rs. 91.45 on November 03, 2026, and opened on an ex-right basis at Rs. 87.95 on November 04, 2026. Since then, it has marked a high/low of Rs. 88.70 / Rs. 80.00. The scrip last closed at Rs. 83.65 as of November 13, 2026. For the last 52 weeks’ it has posted a high/low of Rs. 136.74 / Rs. 80.00.

 

The promoters’ holding has been at 0.00%L for the last three quarters ended on September30, 2026. The counter is kept well above the RI price, with vested interest operations, to tempt investors.

 

CONCLUSION:

  • This is the 2nd RI from CCL since June 2025.
  • It is operating in a highly competitive and fragmented segment.
  • Bumper performance in pre-RI period appears window dressing to fetch fancy valuations.
  • Based on its recent average financial data, the issue appears aggressively priced.
  • There is no harm in skipping this pricey and dicey bet.

 

Review By Dilip Davda on August, 2026

Review Author

DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. My reviews do not cover GMP market and operators game plans. Readers must consult a qualified financial advisor before making any actual investment decisions, based the on information published here. With entry barriers, SEBI wants only well-informed investors to participate in such offers. With crazy listings in the recent past, SME IPOs drew the attention of investors across the board and lead to seer madness. However, as SME issues have entry barriers and continued low preference from the broking community, any reader taking decisions based on any information published here does so entirely at their own risk. The above information is based on information available as of date coupled with market perceptions. The Author has no plans to invest in this offer.

 

About Dilip Davda

Dilip Davda is veteran journalist associated with stock market since 1978. He is contributing to print and electronic media on stock markets/insurance/finance since 1985.

Dilip Davda is a leading reviewer of public issues and NCDs in the primary stock market in India. The knowledge he gained over 3 decades while working in the stock market and a strong relationship with popular lead managers makes his reviews unique. His detailed fundamental and financial analysis of companies coming up with IPOs helps investors in the primary stock market. Dilip Davda has a special interest in analyzing the SME companies and writing reviews about their public issues. His reviews are regularly published online and in news papers.

(Dilip Davda -SEBI registered Research Analyst-Mumbai,

Registration no. INH000003127 (Perpetual)

Email id: dilip_davda@rediffmail.com ).

Related posts

Airfloa Rail BSE SME IPO Review

Compiled by Narendra Joshi

Ashwini Container NSE SME IPO Review

Compiled by Narendra Joshi

વિક્રન એન્જિનિયરિંગ આઈપીઓ સમીક્ષા

Compiled by Narendra Joshi